Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Anti-emetic effects of thalidomide: Evidence, mechanism of action, and future directions
Paul Andrews, Robin S. B. Williams, Gareth J. Sanger
Current Research in Pharmacology and Drug Discovery (2022) Vol. 3, pp. 100138-100138
Open Access | Times Cited: 13

Showing 13 citing articles:

Induced protein degradation for therapeutics: past, present, and future
Hojong Yoon, Justine C. Rutter, Yen-Der Li, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 1
Open Access | Times Cited: 22
Review article: An analysis of the pharmacological rationale for selecting drugs to inhibit vomiting or increase gastric emptying during treatment of gastroparesis
Gareth J. Sanger, Paul Andrews
Alimentary Pharmacology & Therapeutics (2023) Vol. 57, Iss. 9, pp. 962-978
Open Access | Times Cited: 23
Addition of thalidomide for prevention of chemotherapy-induced nausea and vomiting in the second cycle after the failure of four-drug regimen in the first cycle
Nishil Gowda, Mirunalini Ravichandran, Jeyaselvi Indrajithu, et al.
Medical Oncology (2025) Vol. 42, Iss. 4
Closed Access
Serendipity in Neuro-Oncology: The Evolution of Chemotherapeutic Agents
Denise Nadora, Shawyon Ezzati, Brandon Bol, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 7, pp. 2955-2955
Open Access
Synthesis and Characterization of Iron Oxide-Thalidomide Nanoconjugates for Enhanced Anti-Inflammatory Activities
Anoosha Sajjad, R. A. Manzoor, Anila Sajjad, et al.
Journal of Molecular Structure (2025), pp. 142454-142454
Closed Access
An assessment of the effects of neurokinin1 receptor antagonism against nausea and vomiting: Relative efficacy, sites of action and lessons for future drug development
Paul Andrews, John F. Golding, Gareth J. Sanger
British Journal of Clinical Pharmacology (2023) Vol. 89, Iss. 12, pp. 3468-3490
Open Access | Times Cited: 5
Review of Teratogenic Effects of Leflunomide, Accutane, Thalidomide, Warfarin, Tetracycline, and Angiotensin-Converting Enzyme Inhibitors
Raegan B Abadie, Camryn L Keller, Nicholas T Jones, et al.
Cureus (2023)
Open Access | Times Cited: 3
Towards robust pharmacovigilance surveillance systems
Matthew Halma
Open Health (2024) Vol. 5, Iss. 1
Open Access
Thalidomide: History of Research and Perspectives for Its Medical Use (Review)
Д. В. Куркин, D. A. Bakupin, Е. И. Морковин, et al.
Pharmaceutical Chemistry Journal (2024) Vol. 58, Iss. 7, pp. 1001-1010
Closed Access
Time-tracking substances: harnessing the power of article counts over time with SciFindern
Robert Tomaszewski
Scientometrics (2024)
Closed Access
Substance P in nausea and vomiting
Paul Andrews, John A. Rudd, Gareth J. Sanger
Elsevier eBooks (2024), pp. 179-228
Closed Access
Sustained release formulation of doxylamine-pyridoxine combination: a promising way to overcome nausea and vomiting of pregnancy
Fatemeh Fakhari, Sepideh Arbabi Bidgoli, Solmaz Ghaffari
Deleted Journal (2024) Vol. 34, Iss. 4, pp. 357-364
Closed Access
Cancer drugs with high repositioning potential for Alzheimer’s disease
Jad Majeed, Marwan N. Sabbagh, Min H. Kang, et al.
Expert Opinion on Emerging Drugs (2023) Vol. 28, Iss. 4, pp. 311-332
Closed Access | Times Cited: 1
Thalidomid: Fluch, Segen und Triumph eines Schlafmittels
Athanassios Giannis
Springer eBooks (2023), pp. 137-150
Closed Access
Page 1

Scroll to top